Companies in #Protein Degradation

Clinical-stage biopharmaceutical company using its DELigase platform to discover targeted protein degradation and protein elevation therapies for cancer and immune-mediated diseases.

Orionis Biosciences is a life sciences company pioneering conditionally active immunotherapies (A-Kines) and molecular glue drug discovery (AlloGlues) for cancer and immunology. The company has research collaborations with Novartis and Genentech/Roche, and is advancing internal programs in oncology and immunology.